Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (851-860 of 932) with videos related to

Pageof 94
Sort By:
Molecular Medicine (Cambridge, Mass.)|January 10, 2003
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotypeW T Abraham, E M Gilbert, B D Lowes, et al.
Journal of Medicinal Chemistry|August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidinesArie Zask, Jeroen C Verheijen, Kevin Curran, et al.
European Heart Journal|August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trialsMarco Metra, Eric Eichhorn, William T Abraham, et al.
Heart Rhythm O2|March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trialWilliam T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
European Heart Journal|December 19, 2025
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trialJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
JACC. Heart Failure|December 15, 2023
Left Ventricular Ejection Fraction and the Future of Heart Failure PhenotypingMatthew G Dimond, Nasrien E Ibrahim, Mona Fiuzat, et al.
JACC. Cardiovascular Imaging|May 25, 2024
Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT TrialStephan M Pio, Diego Medvedofsky, Victoria Delgado, et al.
JACC. Heart Failure|December 9, 2023
Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel PaperAnuradha Lala, Carine E Hamo, Biykem Bozkurt, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 5, 2003
Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency departmentPeter A McCullough, Judd E Hollander, Richard M Nowak, et al.
Journal of the American College of Cardiology|May 13, 2017
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further ResearchMaria Rosa Costanzo, Claudio Ronco, William T Abraham, et al.
Pageof 94

Showing results (851-860 of 932) with videos related to

Sort By:
Pageof 94
Molecular Medicine (Cambridge, Mass.)|January 10, 2003
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotypeW T Abraham, E M Gilbert, B D Lowes, et al.
Journal of Medicinal Chemistry|August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidinesArie Zask, Jeroen C Verheijen, Kevin Curran, et al.
European Heart Journal|August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trialsMarco Metra, Eric Eichhorn, William T Abraham, et al.
Heart Rhythm O2|March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trialWilliam T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
European Heart Journal|December 19, 2025
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trialJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
JACC. Heart Failure|December 15, 2023
Left Ventricular Ejection Fraction and the Future of Heart Failure PhenotypingMatthew G Dimond, Nasrien E Ibrahim, Mona Fiuzat, et al.
JACC. Cardiovascular Imaging|May 25, 2024
Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT TrialStephan M Pio, Diego Medvedofsky, Victoria Delgado, et al.
JACC. Heart Failure|December 9, 2023
Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel PaperAnuradha Lala, Carine E Hamo, Biykem Bozkurt, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 5, 2003
Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency departmentPeter A McCullough, Judd E Hollander, Richard M Nowak, et al.
Journal of the American College of Cardiology|May 13, 2017
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further ResearchMaria Rosa Costanzo, Claudio Ronco, William T Abraham, et al.
Pageof 94